FDA Establishing ‘Golden’ Manufacturing Facility Records

“Golden” records should give FDA greater certainty about which pharmaceutical manufacturing facilities it regulates – and where they are.

FDA’s latest effort to identify the facilities it regulates, launched this year, will be coordinated by a program integrator the agency anticipates acquiring soon, according to a draft statement of work (SOW) attached to a Dec. 29 request for information.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America